You are a natural scientist, pharmacist or veterinarian, have successfully completed your Master’s degree and would like to do a PhD? If you are interested and ideally have first experiences in virology, are highly motivated and like to work in an international team, then you are the right person for us!
In our department we give PhD students the opportunity to do a scientific doctorate (Dr. rer. nat.).
Since we have already accompanied many PhD students during their doctoral studies, we know what is important. We offer not only exciting and well-designed projects, but also comprehensive support in all practical and theoretical aspects of the work, regular meetings as well as a great team and a cheerful and relaxed working atmosphere! It is also important to us that the PhD students can actively shape their project and that it can be realized in a manageable time frame. Participation in (international) conferences and publication of results are also part of a PhD thesis in the Department of Molecular & Medical Virology.
Some examples of scientific PhD theses from our department can be found below.
If you are interested: Then send your application to firstname.lastname@example.org (including CV, references, cover letter and possible starting date).
Recent PhD projects:
Evolution and Host immune response during Hepaciviral infection
ANDRÉ GÖMER – 2022
Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance
Experimental cross-species infection of donkeys with equine hepacivirus and analysis of host immune signatures
Dose-Dependent Hepacivirus Infection Reveals Linkage between Infectious Dose and Immune Response
Viral and Host Determinants in the replication Cyle of Hepatitis E Virus
TONI LUISE MEISTER – 2021
Meister et al. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function. PNAS (2022).
Virus-host-interactions of hepatitis C virus
VOLKER KINAST – 2020
Kinast. et al. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle. Journal of Hepatology. (2020)